BNP PARIBAS FINANCIAL MARKETS

Holdings History for HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Investment type: Debt / NOTE 1.000% 8/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Price	All Holders
30 Sep 2025	0%	0%	$862,060	611,000	141.09%	Q3 2025
30 Jun 2025	0%	0%	$2,822,768	2,450,000	115.22%	Q2 2025
31 Mar 2025	0%	0%	$3,517,671	2,747,000	128.06%	Q1 2025
31 Dec 2024	0.01%	0%	$6,489,932	6,018,000	107.84%	Q4 2024
30 Sep 2024	0%	0%	$3,456,812	2,911,000	118.75%	Q3 2024
30 Jun 2024	0%	0%	$2,321,000	2,088,000	111.16%	Q2 2024
31 Mar 2024	0%	0%	$2,538,660	2,613,000	97.15%	Q1 2024
31 Dec 2023	0.01%	0%	$3,147,320	3,397,000	92.65%	Q4 2023
30 Sep 2023	0%	0%	$1,733,974	1,857,000	93.38%	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.